Stemler, Jannik http://orcid.org/0000-0001-9152-2469
Kramer, Theresa http://orcid.org/0000-0001-5187-6510
Dimitriou, Vassiliki
Wieland, Ulrike http://orcid.org/0000-0003-3480-4413
Schumacher, Sofie http://orcid.org/0000-0002-8805-1421
Sprute, Rosanne http://orcid.org/0000-0003-2457-6437
Oberste, Max http://orcid.org/0000-0002-1224-5385
Wiesmüller, Gerhard
Rau, Harald http://orcid.org/0000-0001-6681-2288
Pieper, Sally
Bethe, Ullrich http://orcid.org/0000-0001-9979-1671
Lehmann, Clara http://orcid.org/0000-0002-7042-1578
Hellmich, Martin http://orcid.org/0000-0001-5174-928X
Klein, Florian http://orcid.org/0000-0003-1376-1792
Langebartels, Georg
Cornely, Oliver A. http://orcid.org/0000-0001-9599-3137
Clinical trials referenced in this document:
Documents that mention this clinical trial
Mobile PCR-based surveillance for SARS-CoV-2 to reduce visiting restrictions in nursing homes during the COVID-19 pandemic: a pilot study
https://doi.org/10.1007/s15010-021-01716-4
Funding for this research was provided by:
bundesministerium für bildung und forschung (01KX2021)
Universität zu Köln
Article History
Received: 12 July 2021
Accepted: 10 October 2021
First Online: 20 October 2021
Declarations
:
: JS has received research grants by the Ministry of Education and Research (BMBF) for this study and from Basilea Pharmaceuticals Inc. outside the submitted work and has received travel grants by German Society for Infectious Diseases (DGI e.V.) and Meta-Alexander-Foundation. TK, VD SS, RS, MO SP, UB, CL, and FK have nothing to disclose. UW is employed at Institute of Virology, University of Cologne, and has received funding from the Ministry of Education and Research (BMBF) for this study. GW has received research grants by the Ministry of Education and Research (BMBF) for this study. HR has received research grants by the Ministry of Education and Research (BMBF) for this study. MH has received research grants by the Ministry of Education and Research (BMBF) for this study. GL has received research grants by the Ministry of Education and Research (BMBF) for development of the UHC Corona Webtool. OAC is supported by the German Federal Ministry of Research and Education, is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy—CECAD, EXC 2030—390661388, and has received research grants from, is an advisor to, or received lecture honoraria from Actelion, Allecra Therapeutics, Al-Jazeera Pharmaceuticals, Amplyx, Astellas, Basilea, Biosys, Cidara, Da Volterra, Entasis, F2G, Gilead, Grupo Biotoscana, Immunic, IQVIA, Janssen, Matinas, Medicines Company, MedPace, Melinta Therapeutics, Menarini, Merck/MSD, Mylan, Nabriva, Noxxon, Octapharma, Paratek, Pfizer, PSI, Roche Diagnostics, Scynexis, and Shionogi.
: This study was approved by the Ethics Committee (No 20-1500_1) of the Medical Faculty of the University of Cologne. This study complied with ethical standards and all the methods were carried out in accordance with the Declaration of Helsinki.
: Informed consent was obtained as part of the digital registration process at the mobile testing site. Implementation of the UHC Corona Web Tool for this study was registered with the data privacy software 2B Advice PrIME and approved by the UHC data protection body.